Today, stock futures were marginally lower in the early hours ahead of JOLTs data.
Top stock gainers
Shares of biopharmaceutical company Annexon (NASDAQ:ANNX) soared above 35% ahead of a scheduled conference call and webcast to announce GBS phase 3 data, which is coming later today at 8:30 a.m. ET.
GameStop (NYSE:GME) shares jumped 8% in the premarket hours of Tuesday, building on the 21% rise observed on Monday. The recent increase in the meme stock followed another Reddit post from Keith Gill, aka Roaring Kitty. An unsubstantiated screenshot on Reddit revealed a paper gain of $78.6M from his recent purchase of 5M GameStop (GME) shares and 120K June 21 call options.
HealthEquity (NASDAQ:HQY) shares climbed about 6% on outperforming expectations in Q1 earnings, with top-line growth of around 18% and adjusted EBITDA +36% Y/Y. The business also offered a bullish FY2024 forecast, expecting revenue between $1.16B and $1.18B vs. the consensus of $1.16B and adjusted EPS in the range of $2.93 to $3.10, above the average of $2.92.
Top stock losses
Shares of BARK (NYSE:BARK) fell more than 10% after the business posted mixed Q4 earnings, missing top-line estimates and a disappointing outlook. For FQ1, BARK predicts overall sales to be between $113M and $116M, below the expectation of $124M, and FY2025 revenue between $490M and $500M, falling short of the consensus of $511.3M.
Premarket
Gainers
Donaldson (NYSE:DCI) stock jumped 9.1% after the air filter producer reported robust sales, including an 8% boost in its quarterly dividend distribution.
Viking Therapeutics (NASDAQ:VKTX) stock increased 5%, with the biotech business benefiting from the announcement that the institutional investor Dorsey & Whitney Trust had bought a new interest in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.
Intel (NASDAQ:INTC) stock climbed 1.4% after the tech company introduced its next generation Xeon server processors, and priced its Gaudi 3 artificial intelligence accelerator chips below its rivals’ wares.
Tesla (NASDAQ:TSLA) shares increased 0.3% despite Reuters reporting that sales of the EV manufacturer’s China-made electric vehicles declined by 6.6% in May compared to a year ago, citing statistics from the China Passenger Car Association.
Losers
GameStop (NYSE:GME) stock fell 3.3%, retreating after the video game retailer soared over 20% in the previous session on the back of stock influencer Keith Gill, who is known online as “DeepF——-Value” and “Roaring Kitty”, posting a screenshot on social media site Reddit which showed he had made a $116 million bet on the company.
Gitlab (NASDAQ:GTLB) stock slid 2.2% after the software coding platform anticipated weaker-than-expected second-quarter revenue.
BP (NYSE:BP) ADRs sank 2% after ratings agency S&P Global reduced its outlook to ‘stable’ from ‘positive’ citing concerns its share repurchase plans will leave it unable to lower its debts.
Exxon (NYSE:XOM) and Chevron (NYSE:CVX) equities both declined approximately 1%, dragged by the flailing oil price as a group of large producers signaled an increase in production towards the end of the year.
Stock in Focus
Intel (INTC) shares rose 2% before the opening bell after revealing its latest processors and AI chips at Computex in Taiwan. The business released its latest Xeon 6 server CPUs, with E-core and P-core choices, to improve performance and power efficiency for high-intensity data center workloads. Sierra Forest, the Xeon 6 processor with Efficient-cores, improves rack-level consolidation and performance per watt. Intel also revealed that its Gaudi AI accelerator chips would be cheaper than competitors’ to reclaim market share from Nvidia (NVDA) and AMD.
Tuesday saw major oil company shares fall as crude oil prices fell. Exxon Mobil (XOM) and Chevron (CVX) fell by about 1% in premarket trading after major producers signaled a supply rise at the end of the year.
Viking Therapeutics (VKTX) rose 3% in premarket trading on Tuesday after reporting positive 52-week mid-stage NASH trial findings. The experiment already reduced liver fat, but the latest data indicates promise in secondary endpoints like fibrosis and NASH resolution, with the medicine showing much better outcomes than the placebo group and minimal side effects.
BP’s stock sank 2% after S&P downgraded its credit outlook owing to rising debt. The ratings agency believes BP’s share buyback plans will constrain debt reduction as net debt and debt-to-capitalization ratio worsen. A focus on shareholder returns will expand BP’s financial gap with competitors, says S&P.
Must read book about investing – check here
After reporting 8% Y/Y subscription revenue growth in 4Q24, DocuSign (NASDAQ:DOCU) shares rose 10%. Electronic signature business predicts 1Q25 revenue of $704M to $708M, above analysts’ $699.1M forecast. DocuSign expects sales of $2.91B to $2.92B this year, with consensus of $2.91B. Customer adoption of Contract Lifecycle Management and eSignature in StateRAMP-authorized environments was also emphasized by the organization.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.